Showing results (2001-2010 of 5,920) with videos related to
Sort By:
Pageof 592
Arthritis Research & Therapy|June 21, 2018
Patient-reported outcomes from a randomized phase III trial of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritisVibeke Strand, Laure Gossec, Clare W J Proudfoot, et al.Arthritis Research & Therapy|June 23, 2018
Glycation marker glucosepane increases with the progression of osteoarthritis and correlates with morphological and functional changes of cartilage in vivoCatherine Legrand, Usman Ahmed, Attia Anwar, et al.Arthritis Research & Therapy|July 6, 2018
Chemerin 156F, generated by chymase cleavage of prochemerin, is elevated in joint fluids of arthritis patientsLei Zhao, Yasuto Yamaguchi, Xiaomei Ge, et al.Arthritis Research & Therapy|June 1, 2018
Transcription factor motif enrichment in whole transcriptome analysis identifies STAT4 and BCL6 as the most prominent binding motif in systemic juvenile idiopathic arthritisBoris Hügle, Anastasia Schippers, Nadine Fischer, et al.Arthritis Research & Therapy|June 1, 2018
Comparison of US patient, rheumatologist, and dermatologist perceptions of psoriatic disease symptoms: results from the DISCONNECT studyM Elaine Husni, Anthony Fernandez, Brett Hauber, et al.Arthritis Research & Therapy|April 20, 2019
Efficacy and safety of namilumab, a human monoclonal antibody against granulocyte-macrophage colony-stimulating factor (GM-CSF) ligand in patients with rheumatoid arthritis (RA) with either an inadequate response to background methotrexate therapy or an inadequate response or intolerance to an anti-TNF (tumour necrosis factor) biologic therapy: a randomized, controlled trialPeter C Taylor, Didier Saurigny, Jiri Vencovsky, et al.Arthritis Research & Therapy|August 23, 2003
SLE - hematopoietic stem cell transplantation for systemic lupus erythematosusRichard K Burt, Ann E TraynorArthritis Research & Therapy|August 23, 2003
Higher susceptibility to Fas ligand induced apoptosis and altered modulation of cell death by tumor necrosis factor-alpha in periarticular tenocytes from patients with knee joint osteoarthritisAndreas Machner, Anja Baier, Aline Wille, et al.Arthritis Research & Therapy|August 23, 2003
Vgamma9/Vdelta2 T lymphocytes in Italian patients with Behçet's disease: evidence for expansion, and tumour necrosis factor receptor II and interleukin-12 receptor beta1 expression in active diseaseGiovanni Triolo, Antonina Accardo-Palumbo, Francesco Dieli, et al.Arthritis Research & Therapy|August 23, 2003
A comparative study of the inhibitory effects of interleukin-1 receptor antagonist following administration as a recombinant protein or by gene transferJean-Noel Gouze, Elvire Gouze, Glyn D Palmer, et al.Pageof 592